
AstraZeneca tokenized stock price
rAZNrAZN/USD price calculator
Live AstraZeneca price today in USD
Do you think the price of AstraZeneca will rise or fall today?
In-depth analysis of AstraZeneca's market trends today
AstraZeneca market summary
The current price of AstraZeneca (rAZN) is $164.81, with a 24-hour change of -0.11%. The current market capitalization is approximately --, and the 24-hour trading volume is $0.00.
Market Structure and Price Behaviour
AstraZeneca (rAZN) is a tokenized representation linked to AstraZeneca equity, so its valuation is primarily influenced by the underlying company, pharmaceutical-sector sentiment, currency conversion, liquidity, and the tokenization mechanism rather than by a standalone crypto narrative.
Recent market data suggests a mixed short-term structure: momentum readings around RSI 38–47 indicate neutral-to-soft conditions, while a reported MACD near -0.08 points to limited bullish momentum. The broader structure remains range-bound until the token can establish sustained demand above nearby resistance.
Key Technical Levels
The first support zone is approximately $162.20–$161.00, where short-term average support and recent tokenized-equity pricing have clustered. A break below this area could expose the $156.80–$157.00 region, followed by a deeper risk zone near $150.00.
Initial resistance is located around $166.50–$168.70. A sustained move above that band would improve the short-term structure and open a potential path toward $172.00–$175.00. Failure to reclaim resistance would favour continued consolidation rather than a decisive trend reversal.
Fundamental and News Drivers
AstraZeneca’s latest operating backdrop remains constructive, with reported first-half core operating profit and core earnings growth of approximately 11%, while revenue increased around 6%. Oncology and rare-disease businesses were identified as important contributors, supporting the fundamental case for the underlying asset.
Pipeline developments remain a two-sided factor. Progress in obesity and GLP-1-related research can strengthen long-term sentiment, but setbacks in late-stage trials, patent-expiry concerns, development costs, and competitive pressure may create sharp downside reactions in a relatively thinly traded tokenized instrument.
Reports that merger discussions involving Bristol Myers Squibb were dismissed helped reduce one source of uncertainty around AstraZeneca’s independent strategy. However, merger speculation can still generate short-term volatility because investors must reassess capital allocation, strategic focus, and execution risk whenever such reports emerge.
Scenario Outlook
Optimistic scenario: Holding above $162.20, followed by a decisive break above $168.70, would signal improving demand. In that case, the next technical objectives would be approximately $172.00 and $175.00, provided volume and the underlying equity remain supportive.
Neutral scenario: If RSI remains below 50 and MACD stays negative, rAZN may continue oscillating between roughly $161.00 and $168.70. Range strategies would be more appropriate than aggressive directional positioning in this condition.
Bearish scenario: A sustained close below $161.00 would weaken the structure, while a break beneath $156.80 could accelerate the move toward $150.00. Thin liquidity and tracking differences may amplify declines compared with the underlying AstraZeneca equity.
Trading Approaches
Conservative investors may wait for a confirmed close above $168.70 and stronger momentum before adding exposure. A protective exit below $162.20 would help limit risk if the breakout fails.
Range traders may consider staged entries near $161.00–$162.20, with partial profit-taking around $166.50–$168.70. This approach should account for spreads, liquidity, tracking risk, and possible gaps in tokenized-equity pricing.
Long-term investors should treat rAZN as a hybrid equity-linked digital asset rather than a conventional decentralized cryptocurrency. Position sizing should remain moderate, with attention to AstraZeneca’s pipeline execution, earnings growth, regulatory developments, and the token’s redemption and liquidity conditions.
Market Consensus
Recent analyst commentary remains broadly constructive on AstraZeneca’s diversified pipeline and valuation, with several ratings retaining a Buy bias and a reported 12-month target near 16,500 GBp for the underlying London-listed shares. The consensus is therefore cautiously optimistic over the medium term, but the technical picture for AstraZeneca (rAZN) is not yet decisively bullish: a breakout above $168.70 would be needed to confirm renewed momentum, while a loss of $161.00 would shift the balance toward downside risk.
Now that you understand the market, it's time to start trading. AstraZeneca (rAZN) is actively traded on Bitget Exchange, one of the world's largest cryptocurrency platforms with over 120 million registered users. Bitget offers spot trading for rAZN/USDT with highly competitive fees, as low as 0% for makers and 0.03% for takers. The platform supports more than 1300 cryptocurrencies including AstraZeneca, maintains a protection fund exceeding $300 million, and provides 24/7 trading with deep liquidity. Bitget consistently ranks among the top exchanges by rAZN trading volume.
Sign up for a free Bitget account and start trading now!Risk disclaimer
The above analysis is based on Bitget's real-time chart data and technical indicators, compiled and reviewed by the Bitget research team. It is for reference only and does not constitute investment advice. Cryptocurrency prices are highly volatile. Please make investment decisions based on your own risk tolerance.

GetAgent: Your AI for smarter trading decisions
AstraZeneca market info
You can trade rAZN on Bitget
Hot stock assets trading on Bitget
Detailed introduction to Bitget rToken (rAZN)
In short, rAZN is a tokenized stock issued by licensed issuer Reality, pegged 1:1 to real AstraZeneca stock. It supports 24/7 trading, fractional shares, and dividends, and can be used as margin for the platform's unified trading account and USDT-M futures.
Buy rAZNHow Bitget rToken (rAZN) works
During U.S. market hours—including the regular session, pre-market, after-hours, and overnight sessions—spot orders for rAZN are routed directly through a broker to the Nasdaq or NYSE order book. Once the trade is executed on the U.S. stock market, the execution result is reflected in the on-exchange spot order record. Any order you place for rAZN while the U.S. market is open will also appear on the Nasdaq or NYSE order book. This means that during U.S. market hours, the trading price and liquidity of rAZN are exactly the same as those of the underlying stock. Orders for rAZN and their execution results are part of the U.S. stock market. There is no spread or so-called de-pegging, because rAZN trades are executed directly on the U.S. stock market itself. The execution price you see for rAZN is identical to the stock's price at that exact moment.
This makes rAZN fundamentally different from traditional RWA tokens. The price of a traditional RWA asset is determined by on-chain liquidity and trading activity, whereas the price of rAZN is directly equivalent to the stock price—it does not rely on any other mechanism to peg the asset's price. In terms of trading outcomes, trading rAZN is no different from trading the stock directly.
Buy rAZN with crypto assets on Bitget for the best stock trading experience
Bitget's spot trading market has listed over 500 rTokens (including rAZN), offering native U.S. stock liquidity 24/5, with some trading pairs supporting 24/7 trading.
Market liquidity: The only tokenized stock that aligns with the market price and liquidity of major U.S. stock exchanges such as Nasdaq and the NYSE.
Maximum capital efficiency: rTokens can be used within the unified ecosystem for margin, Crypto Loans, Earn, and more, expanding the ways your assets can be used.
More flexible trading: Supports stablecoin deposits, T+0 fund turnover, 24/5 trading, with some pairs supporting 24/7 trading.
Fund security: The only RWA asset in the industry subject to daily third-party Proof of Reserves (PoR) audits, ensuring transparent asset reserves and protecting user funds.
Dividend rights: Eligible dividends are paid out to users' accounts in USDT.
Hold rAZN and enjoy corporate actions aligned with the underlying stock
Corporate actions involving rAZN (including dividend payments, stock splits, and reverse splits) are handled in the same way that a traditional broker would handle a stock position.
While holding rAZN, whenever AstraZeneca stock pays a USD dividend, Reality automatically converts it into an equivalent amount of stablecoin (USDT) and distributes it 1:1 to the Bitget accounts of rAZN holders. As a result, holding rAZN entitles you to the same dividend rights as holding the actual stock, with the entire process handled automatically by the platform, requiring no manual action. It should be noted that dividends are subject to a flat 30% withholding tax applied by the U.S. to foreign investors. For users holding high-dividend assets (such as certain tech stocks or ETF-linked tokens), this means they can earn steady passive income on top of capital appreciation, further boosting the overall return on their holdings.
The issuer of rAZN is based in El Salvador. Therefore, the withholding tax applicable to rAZN follows the U.S. withholding tax rules for El Salvador.
Hold rAZN and enjoy the flexibility of a crypto asset
Whether you're using a traditional broker or another platform, deposits and withdrawals are rarely a seamless experience. Traditional brokers may take time to process deposits. After a stock is sold, withdrawals typically take one to two days to process, and the funds may take even longer to arrive. Securities holdings also cannot be split, transferred, or reallocated. By contrast, rAZN offers far greater flexibility than traditional stocks.
1. rAZN can be sold on the exchange, and the proceeds are immediately available for transfer, with no T+1 restriction.
2. rAZN can be freely transferred, withdrawn, or moved between sub-accounts, offering great flexibility and convenience. rAZN is essentially a regular crypto asset, with no difference in use from Bitcoin.
3. rAZN can be used directly as margin in a unified trading account to open futures positions. This allows users to participate in derivatives trading without selling their stock holdings, improving capital efficiency.
4. rAZN can be used as collateral to borrow crypto assets such as USDT, USDC, and BTC on the platform for further trading or to purchase other rToken assets. This is similar to the margin lending services offered by traditional brokers and helps improve capital efficiency.
Understanding the risks
The advantage of rAZN is that its price is exactly the same as the underlying stock's while also benefiting from the stock's deep liquidity. Even for less actively traded stocks, institutions don't need to worry about unexpected liquidations caused by price spikes resulting from insufficient on-exchange liquidity, as can happen with traditional tokens.
During weekends, when the U.S. stock market is closed, rAZN continues to function as collateral without interruption. Even though rAZN remains tradable over the weekend, its collateral value continues to be based on the last price before the U.S. market closes on Friday. This fixed index price is used for risk calculations, helping maintain a relatively stable collateral value and liquidation risk profile.
Why choose Bitget rToken? What are the main advantages of Bitget rToken over traditional stock investing?
Buy rAZN nowWhere is the best place to buy crypto like AstraZeneca (rAZN)?
AstraZeneca Price history (USD)
What is the highest price of AstraZeneca?
What is the lowest price of AstraZeneca?
AstraZeneca price prediction
What will the price of rAZN be in 2027?
In 2027, based on a +5% annual growth rate forecast, the price of AstraZeneca(rAZN) is expected to reach $179.46; based on the predicted price for this year, the cumulative return on investment of investing and holding AstraZeneca until the end of 2027 will reach +5%. For more details, check out the AstraZeneca price predictions for 2026, 2027, 2030-2050.What will the price of rAZN be in 2030?
Hot promotions
Global AstraZeneca prices
How to buy AstraZeneca(rAZN)

Create Your Free Bitget Account

Verify Your Account
